Health Care and Pharma | Research Reports, News, Events, Research on Demand

Research Reports Titles

  • United States e-Clinical Trial Solutions Market Report 2021

    Notes: Sales, means the sales volume of e-Clinical Trial Solutions Revenue, means the sales value of e-Clinical Trial Solutions This report studies sales (consumption) of e-Clinical Trial Solutions in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering BioClinica PAREXEL Perceptive Informatics EClinical Solutions Ecrfplus Clincase Merge Oracle Medidata Solutions Clinpal NTT DATA DATATRAK Omnicomm MedNet Solutions Prelude Dynamics Nextrials DSG EClinForce Almac ArisGlobal DigiGenomics Pharma & Healthcare Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Clinical data management system (CDMS) Clinical trial management system (CTMS) solutions Electronic clinical outcomes assessment (eCOA) solutions Randomization and trial supply management (RTSM) solutions Others? Split by applications, this report focuses on sales, market share and growth rate of e-Clinical Trial Solutions in each application, can be divided into Medical Laboratory Hospitals Pharmaceutical companies

    • Release Date: September 14, 2016
    • Price: USD 3800
    • Format: PDF

  • Global Animal Genetics Market Research Report 2021

    The Global Animal Genetics Industry Report 2016 is a professional and in-depth study on the current state of the Animal Genetics industry. The report provides a basic overview of the industry including definitions, classifications, and applications. The Animal Genetics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states consumption, supply and demand Figures, revenue and gross margins. The report focuses on global major leading industry players providing information such as company profiles, revenue and contact information. The Animal Genetics industry development trends and marketing channels are analyzed. With 219 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    • Release Date: September 06, 2016
    • Price: USD 2900
    • Format: PDF

  • Argentina Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

    Argentina Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary GlobalData s new report, Argentina Cardiovascular Device Market Outlook to 2022, provides key market data on the Argentina Cardiovascular Device market. The report provides value, in millions of US dollars and volume (in units) within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends) The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Cardiovascular Device market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for Cardiovascular Device market. - Global corporate-level profiles of key companies operating within the Argentina Cardiovascular Device market. - Key players covered include Medtronic plc, Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what s the most preferred mode of product distribution - Identify, understand and capitalize.

    • Release Date: September 01, 2016
    • Price: USD 5995
    • Format: PDF

  • Austria Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

    Austria Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary GlobalData s new report, Austria Cardiovascular Device Market Outlook to 2022, provides key market data on the Austria Cardiovascular Device market. The report provides value, in millions of US dollars and volume (in units) within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends) The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Cardiovascular Device market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for Cardiovascular Device market. - Global corporate-level profiles of key companies operating within the Austria Cardiovascular Device market. - Key players covered include Medtronic plc, Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what s the most preferred mode of product distribution - Identify, understand and capitalize.

    • Release Date: September 01, 2016
    • Price: USD 5995
    • Format: PDF

  • Belgium Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

    Belgium Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary GlobalData s new report, Belgium Cardiovascular Device Market Outlook to 2022, provides key market data on the Belgium Cardiovascular Device market. The report provides value, in millions of US dollars and volume (in units) within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends) The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Cardiovascular Device market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for Cardiovascular Device market. - Global corporate-level profiles of key companies operating within the Belgium Cardiovascular Device market. - Key players covered include Medtronic plc, Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what s the most preferred mode of product distribution - Identify, understand and capitalize.

    • Release Date: September 01, 2016
    • Price: USD 5995
    • Format: PDF

  • Chile Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

    Chile Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary GlobalData s new report, Chile Cardiovascular Device Market Outlook to 2022, provides key market data on the Chile Cardiovascular Device market. The report provides value, in millions of US dollars and volume (in units) within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends) The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Cardiovascular Device market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for Cardiovascular Device market. - Global corporate-level profiles of key companies operating within the Chile Cardiovascular Device market. - Key players covered include Medtronic plc, Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what s the most preferred mode of product distribution - Identify, understand and capitalize.

    • Release Date: September 01, 2016
    • Price: USD 5995
    • Format: PDF

  • Czech Republic Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

    Czech Republic Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary GlobalData s new report, Czech Republic Cardiovascular Device Market Outlook to 2022, provides key market data on the Czech Republic Cardiovascular Device market. The report provides value, in millions of US dollars and volume (in units) within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends) The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Cardiovascular Device market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for Cardiovascular Device market. - Global corporate-level profiles of key companies operating within the Czech Republic Cardiovascular Device market. - Key players covered include Medtronic plc, Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what s the most preferred mode of product distribution - Identify, understand and capitalize.

    • Release Date: September 01, 2016
    • Price: USD 5995
    • Format: PDF

  • Denmark Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

    rophysiology, Prosthetic Heart Valves and Others Summary GlobalData s new report, Denmark Cardiovascular Device Market Outlook to 2022, provides key market data on the Denmark Cardiovascular Device market. The report provides value, in millions of US dollars and volume (in units) within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends) The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Cardiovascular Device market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for Cardiovascular Device market. - Global corporate-level profiles of key companies operating within the Denmark Cardiovascular Device market. - Key players covered include Medtronic plc, Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what s the most preferred mode of product distribution - Identify, understand and capitalize.

    • Release Date: September 01, 2016
    • Price: USD 5995
    • Format: PDF

  • Egypt Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

    Egypt Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary GlobalData s new report, Egypt Cardiovascular Device Market Outlook to 2022, provides key market data on the Egypt Cardiovascular Device market. The report provides value, in millions of US dollars and volume (in units) within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends) The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Cardiovascular Device market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Monitoring Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves and Clot Management Devices. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for Cardiovascular Device market. - Global corporate-level profiles of key companies operating within the Egypt Cardiovascular Device market. - Key players covered include Medtronic plc, St. Jude Medical, Inc., Abbott Laboratories and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what s the most preferred mode of product distribution - Identify, understand and capitalize.

    • Release Date: September 01, 2016
    • Price: USD 5995
    • Format: PDF


Create Account



Log In Your Account